Provided by Tiger Trade Technology Pte. Ltd.

Phio Pharmaceuticals

0.9788
+0.00570.59%
Post-market: 0.9558-0.0230-2.35%19:28 EDT
Volume:43.23K
Turnover:42.21K
Market Cap:11.37M
PE:-0.73
High:0.9999
Open:0.9700
Low:0.9700
Close:0.9731
52wk High:4.19
52wk Low:0.8127
Shares:11.62M
Float Shares:11.55M
Volume Ratio:0.39
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3423
EPS(LYR):-1.4535
ROE:-113.71%
ROA:-65.77%
PB:0.90
PE(LYR):-0.67

Loading ...

Phio Pharmaceuticals to Present at NIBA 153rd Conference, Updates PH-762 Program

Reuters
·
Oct 05

Phio Pharmaceuticals Director Ronald Todd Plott Reports $10,350 Common Share Purchase

Reuters
·
Oct 01

Phio Pharmaceuticals Expands Equity Incentive Pool at Meeting

TIPRANKS
·
Sep 29

Phio Pharmaceuticals Holds Annual Shareholder Meeting Via Webcast

Reuters
·
Sep 29

Phio Pharmaceuticals Director Patricia A. Bradford Acquires 6,500 Common Shares Valued at $6,582.55

Reuters
·
Sep 26

Phio Pharmaceuticals CEO Robert J. Bitterman Acquires $2,057.80 in Common Shares

Reuters
·
Sep 24

Phio Pharmaceuticals to Present PH-762 Clinical Update at Life Sciences Future Conference

Reuters
·
Sep 23

Phio Director Patricia A. Bradford Buys 12,000 Shares Worth $12,360

Reuters
·
Sep 17

Phio Pharmaceuticals Submits FDA Briefing Package for PH-762 Phase 2b Plan in Skin Cancer

Reuters
·
Sep 14

Phio Pharmaceuticals to Meet Investors at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 11

Phio Pharmaceuticals Price Target Maintained with a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 26

Insider Move: Phio Pharmaceuticals Director Quietly Boosts His Stake

TIPRANKS
·
Aug 21

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Purchase of $10,600 in Common Shares

Reuters
·
Aug 20

Phio Pharmaceuticals Announces Annual Shareholder Meeting

Reuters
·
Aug 15

Phio Pharma Wins U.S. Patent Allowance for BRD4-Targeting Intasyl Compound PH-894

Reuters
·
Aug 11

Phio Net Loss Widens to $4.14 Million in Q2 FY26

Reuters
·
Aug 07

Phio Pharmaceuticals Director Ronald Todd Plott Files Initial Beneficial Ownership Statement

Reuters
·
Jul 31

Phio Pharma Corrects Date for Renmark Virtual Non-deal Roadshow Presentation

Reuters
·
Jul 23

Phio Pharmaceuticals Names Dermatologist R. Todd Plott to Board

Reuters
·
Jul 21

Phio Pharma Wins US, Canada Patent Allowances for Intasyl Sirna Compounds

Reuters
·
Jul 15